5‐α‐Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review

@article{Wilt20105ReductaseIF,
  title={5‐α‐Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review},
  author={T. Wilt and R. MacDonald and K. Hagerty and P. Schellhammer and J. Tacklind and M. Somerfield and B. Kramer},
  journal={BJU International},
  year={2010},
  volume={106}
}
  • T. Wilt, R. MacDonald, +4 authors B. Kramer
  • Published 2010
  • Medicine
  • BJU International
  • •  To estimate the benefits and harms of 5‐α‐reductase inhibitors (5‐α‐RIs) in preventing prostate cancer. 
    45 Citations
    Therapy‐associated effects in the prostate gland
    • 34
    Risk adapted chemoprevention for prostate cancer: an option?
    • 7
    Endocrine prevention and treatment of prostate cancer
    • T. Tammela
    • Biology, Medicine
    • Molecular and Cellular Endocrinology
    • 2012
    • 29
    A Perspective on Prostate Carcinogenesis and Chemoprevention
    • 7
    • PDF
    Primary prevention and early diagnosis of prostate cancer: recommendations from the prevention and early diagnosis working group of the Spanish Society of Medical Oncology (SEOM)
    • Á. Pinto, P. Pérez Segura
    • Medicine
    • European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation
    • 2016
    • 1

    References

    SHOWING 1-10 OF 33 REFERENCES
    Five-alpha-reductase Inhibitors for prostate cancer prevention.
    • 61
    Finasteride (MK‐906) in the treatment of benign prostatic hyperplasia
    • Medicine
    • The Prostate
    • 1993
    • 54
    The influence of finasteride on the development of prostate cancer.
    • 2,445
    • PDF
    Prostate cancer prevention and finasteride.
    • 19
    Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
    • 231
    • PDF
    Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
    • 277
    • PDF
    The effect of finasteride in men with benign prostatic hyperplasia.
    • P. Walsh
    • Medicine
    • The Journal of urology
    • 1993
    • 885